Moleculin highlights Annamycin's non-cardiotoxic profile in CEO video

Go back to Moleculin highlights Annamycin's non-cardiotoxic profile in CEO video
METABASIS THERAPEUT (NASDAQ: MBRX) Delayed: 2.51 +0.05 (2.03%)
Previous Close $2.46    52 Week High $9.58 
Open $2.46    52 Week Low $2.34 
Day High $2.64    P/E N/A 
Day Low $2.40    EPS $-0.34 
Volume 270,067